Its only related to the conversion of partly paid shares. No point selling out now i reckon. If anything this may be the last time to buy some at these prices before they announce they are in partnership with one the major medical device players in the U.S , the technology they have is unique also they dont have any competitors so they will have the market to themselves.
Its only related to the conversion of partly paid shares. No...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
